RxDoctor Payments Data

Courtney Clark

Physician Assistant · Cordova, TNNPI 1477079085

Payments from drug & device makers

$5,115in general payments, 2019–2025

Across 215 payments — averaging $23.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alkermes, Inc.$1K
  • Johnson & Johnson$832
  • Otsuka America Pharmaceutical, Inc.$720
  • E.r. Squibb & Sons, L.L.C.$517
  • Neurocrine Biosciences, Inc.$429
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$345
  • plus $1K from 13 others

What the payments were for

  • Food & beverage$4,95897%
  • Education$1573%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,115 in reported general payments places this provider in the 90th percentile of 2,404 physician assistant providers in Tennessee.

See all physician assistant providers in Tennessee

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega TrinzaPaliperidone Palmitate12$99,219
Invega SustennaPaliperidone Palmitate26$59,743
Aripiprazole32$2,296
Oxcarbazepine12$1,698
Lurasidone Hcl13$963
Ziprasidone Hcl11$886
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine14$808
Olanzapine32$779
Mirtazapine36$739
Divalproex Sodium ErDivalproex Sodium17$645
Hydroxyzine Pamoate15$460
Hydroxyzine Hcl15$443
Fluphenazine Decanoate17$427
Haloperidol17$424
Quetiapine Fumarate25$411

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Trinza, Invega Sustenna$832$158,96238 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,404 physician assistant providers in Tennessee.

Other physician assistant in Cordova

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →